# Vanqua Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vanqua-bio

- Industry: Biotechnology
- Headquarters: Chicago, US
- Website: www.vanquabio.com
- Total disclosed funding: $85M
- Latest round: Series B (Aug 27, 2021)
- Investors on record: 9

## About

Founded in 2019 and based in Illinois, US, Vanqua Bio operates as a biopharmaceutical company that develops and discovers treatments for neurodegenerative diseases. The company was co-founded by Dr. Dimitri Krainc and Dr. James Sullivan. In August 2024, Vanqua Bio raised USD 45 million in series B funding from other unspecified investors.

The company operates Vanqua Bio, a technology platform that utilizes human genetics and patient-derived neuronal cells to identify, validate, and clinically translate novel disease pathways associated with lysosomal dysfunction of the immune system. The company's program targets glucocerebrosidase (GCase) as a treatment for Parkinson’s disease (PD) and all forms of Gaucher disease or lysosomal storage disorder. Additional programs address the overactivation of the innate immune system in central and peripheral neurodegenerative disorders, including ALS and Alzheimer’s disease.

The company plans to use the August 2024 funding to continue developing medications to treat Parkinson's and Alzheimer's diseases.

## Funding rounds

- Series B, Aug 27, 2021, $85M — OrbiMed Advisors, OUP (Osage University Partners), Pontifax Venture Capital, Omega Funds, Casdin Capital, Eli Lilly & Company, Surveyor Capital, Logos Capital, Avoro Capital Advisors

## Investors

- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series B
- OUP (Osage University Partners) (https://capitalatlas.ai/funds/oup-osage-university-partners) — Series B
- Pontifax Venture Capital (https://capitalatlas.ai/funds/pontifax-venture-capital) — Series B
- Omega Funds (https://capitalatlas.ai/funds/omega-funds) — Series B
- Casdin Capital (https://capitalatlas.ai/funds/casdin-capital) — Series B
- Eli Lilly & Company — Series B
- Surveyor Capital — Series B
- Logos Capital (https://capitalatlas.ai/funds/logos-capital) — Series B
- Avoro Capital Advisors — Series B